- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.08. | Cibus targets $200M annual royalty revenue from rice traits as regulatory landscape evolves | 2 | Seeking Alpha | ||
| 14.08. | Cibus GAAP EPS of -$0.61, revenue of $0.09M | 2 | Seeking Alpha | ||
| 14.08. | Cibus, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 12.08. | Cbus invests in Atmos Renewables portfolio | 1 | reNews | ||
| 07.08. | Nrep sells hypermarket to real estate investor Cibus | 3 | EuropaProperty.com | ||
| 05.08. | What's New In Investments, Funds? - PGIM, Cibus Capital | 1 | WealthBriefing | ||
| CIBUS Aktie jetzt für 0€ handeln | |||||
| 23.07. | Cibus kündigt Stellenabbau von 34 Positionen im Zuge strategischer Neuausrichtung an | 2 | Investing.com Deutsch | ||
| 23.07. | Cibus, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.07. | Cibus announces layoffs as part of strategic focus on rice traits | 1 | Investing.com | ||
| 23.07. | Cibus, Inc.: Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities | 151 | GlobeNewswire (Europe) | Previously Announced Strategy Focus Prioritizes Opportunities in Rice and Biofragrance Products and Sustainable Ingredients with Initiatives Expected to Reduce Annual Net Cash Usage to Approximately... ► Artikel lesen | |
| 22.07. | Cibus Expands Retail Real Estate Portfolio With Ten Acquisitions | 1 | ESM Magazine | ||
| 17.06. | Cibus and John Innes Centre announce ongoing collaboration with potential to revolutionise fertilizer use in farming | 1 | World Fertilizer | ||
| 12.06. | Cibus Slides on Alliance with John Innes Centre | 1 | Baystreet.ca | ||
| 11.06. | Cibus Acquires Grocery Stores In The Netherlands And Denmark | 1 | ESM Magazine | ||
| 10.06. | Cibus, Inc.: Cibus, Inc. Announces Closing of $27.5 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 06.06. | Cibus-Aktie steigt nach USDA-Deregulierung neuer Raps-Eigenschaft | 1 | Investing.com Deutsch | ||
| 06.06. | Cibus stock rises on USDA deregulation of new canola trait | 1 | Investing.com | ||
| 06.06. | Cibus Canola-Merkmal erhält USDA-Status als nicht reguliert | 1 | Investing.com Deutsch | ||
| 06.06. | Cibus, Inc.: USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations | 400 | GlobeNewswire (Europe) | SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced... ► Artikel lesen | |
| 05.06. | Cibus Prices $27.5 Mln Public Offering To Advance Gene-Edited Rice Traits | - | RTTNews |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 85,65 | +0,06 % | Paukenschlag beim Übernahmekandidaten! 100 %-Aktie BioNxt Solutions lässt BioNTech und Co. hinter sich! | Die Aktie von BioNxt ist endlich angesprungen. Anfang Juli hatten wir zuletzt auf die Chancen des kanadisch-deutschen Biowissenschaftsunternehmens hingewiesen. Seitdem ist die Aktie um fast 100 % gestiegen... ► Artikel lesen | |
| EVOTEC | 6,000 | +0,03 % | Die Blaupause für KI-Medikamentenentwicklung: So nutzen Evotec, NetraMark Holdings und BioNTech die neuen Möglichkeiten | Die Pharmabranche befindet sich mitten in einer Revolution. Künstliche Intelligenz verkürzt die Wirkstoffentwicklung von Jahren auf Monate und steigert die Trefferquote dramatisch. Datengetriebene Prognosen... ► Artikel lesen | |
| CUREVAC | 4,618 | +0,70 % | CureVac mit EILMELDUNG: Könnte die Aktie am Montag komplett einbrechen - Experten warnen!!! | ||
| MODERNA | 20,610 | +0,12 % | Moderna, Inc.: Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 | CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications... ► Artikel lesen | |
| PAION | 0,013 | -50,00 % | Paion Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| NOVAVAX | 6,377 | -0,20 % | H.C. Wainwright startet Coverage für Novavax mit "Buy"-Rating und Kursziel von 10 US-Dollar | ||
| ILLUMINA | 85,45 | -0,05 % | Illumina, Inc.: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 | Revenue of $1.06 billion for Q2 2025, down 3% from Q2 2024 on both a reported and constant currency basis
GAAP operating margin of 20.2% and non-GAAP operating... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | - | - | Boehringer Ingelheim Limited: Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases | · Collaboration strengthens Boehringer's pipeline in Eye Health.· Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an... ► Artikel lesen | |
| BRAIN BIOTECH | 2,330 | +4,48 % | EQS-News: BRAIN Biotech AG: Corbion und BRAIN Biotech arbeiten gemeinsam an Technologien für naturbasierte Inhaltsstoffe der Zukunft | EQS-News: BRAIN Biotech AG
/ Schlagwort(e): Kooperation
Corbion und BRAIN Biotech arbeiten gemeinsam an Technologien für naturbasierte Inhaltsstoffe der Zukunft
25.08.2025... ► Artikel lesen | |
| EDITAS MEDICINE | 2,149 | -2,01 % | Editas Medicine, Inc.: Editas Medicine Announces Second Quarter 2025 Results and Business Updates | Company to select lead development candidate in September; on track to file IND by mid-2026 and achieve human proof-of-concept by year-end 2026 First IND/CTA accepted for CD19 HD Allo CAR T program... ► Artikel lesen | |
| TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 7,144 | +0,62 % | BioCryst Pharmaceuticals, Inc.: BioCryst Announces Departure of Dr. Helen Thackray | RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Dr. Helen Thackray, chief research and development officer, will... ► Artikel lesen | |
| IBIO | 0,675 | -2,88 % | iBio stock price target lowered to $1.60 by Brookline Capital Markets | ||
| CENTOGENE | 0,110 | 0,00 % | Research and Markets: Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com | The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe... ► Artikel lesen | |
| TME PHARMA | 0,111 | 0,00 % | TME Pharma N.V.: TME Pharma to raise €500k through new bond issue and receives new notice of shareholding | TME Pharma is raising additional funds to accelerate the Company's fundamental activities and to increase its budget for its treasury investment strategy TME Pharma has secured binding... ► Artikel lesen |
Das Unternehmen CIBUS INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,21 % bei einem Aktienkurs von 1,330 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIBUS INC finden Sie auf Wallstreet Online.